SOC

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma

Retrieved on: 
Thursday, March 28, 2024
SOC, Survival, Fast track (FDA), Safety, Patient, Food and Drug Administration, Standard of care, Doctor of Philosophy, MD, Clinical trial, Therapy, Injection, FDA, Drug development, CADL, Food, Serology, Pharmaceutical industry

“Dosing patients with multiple injections represents the next step forward in the development of CAN-3110 for rHGG,” said Paul Peter Tak, MD, PhD, FMedSci, President and CEO of Candel. “The observed data suggest that repeated injections of CAN-3110 are well tolerated, supporting the design of a future phase 2 clinical trial in this indication. We’re excited by our recent progress -- as illustrated by the publication in Nature, CAN-3110’s recent FDA Fast Track designation, and the collaboration with Batavia Biosciences -- to accelerate the development and production of CAN-3110, along with our update presented today. Together, we hope this will help to accelerate the development of a better treatment for patients with high unmet need.”

Key Points: 
  • The first cohort of patients were treated with multiple injections of CAN-3110 in the ongoing phase 1b clinical trial.
  • A second cohort is being planned for enrollment in the ongoing phase 1b clinical trial of CAN-3110.
  • The data were presented today during the 5th Glioblastoma Drug Development Summit in Boston, Massachusetts.
  • Results from the ongoing phase 1b clinical trial were published in Nature in Q4 2023.

TASKING and Andes announce FuSa compliant Compiler support for Andes RISC-V ASIL Compliant Automotive IP

Retrieved on: 
Wednesday, March 27, 2024
TASKING, SOC, DSP, Partnership, ASIL, ADAS, Computer security, Ecosystem, Andes Technology, ISO, Fusa, Silicon, Risk management

Munich, Germany, March 27, 2024 (GLOBE NEWSWIRE) -- TASKING proudly announces that its ISO 26262 (functional safety) and ISO/SAE 21434 (cybersecurity) compliant compilers now fully support the Andes FuSa certified RISC-V IP.

Key Points: 
  • Munich, Germany, March 27, 2024 (GLOBE NEWSWIRE) -- TASKING proudly announces that its ISO 26262 (functional safety) and ISO/SAE 21434 (cybersecurity) compliant compilers now fully support the Andes FuSa certified RISC-V IP.
  • The newly introduced RISC-V compiler, compliant with ASIL D standards, seamlessly supports both current and forthcoming FuSa certified Andes RISC-V cores.
  • These advancements underscore Andes' ability to provide tailored solutions for diverse automotive applications, highlighting its leading expertise in the automotive RISC-V IP market.
  • Leveraging TASKING's advanced FuSa and Cybersecurity processes, our users can fast-track compliance efforts, accelerating the time-to-market of RISC-V based automotive software solutions."

Efabless Launches an "AI Wake Up Call" Open-Source Silicon Design Challenge

Retrieved on: 
Tuesday, March 26, 2024
KWS, ChatGPT, Caravel, SOC, MFCC, PALO, Environment, AI, Silicon, Medical device

PALO ALTO, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Efabless Corporation, the creator platform for chips, has officially launched its 4th AI Generated Open-Source Silicon Design Challenge, themed "AI Wake Up Call!"

Key Points: 
  • PALO ALTO, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Efabless Corporation, the creator platform for chips, has officially launched its 4th AI Generated Open-Source Silicon Design Challenge, themed "AI Wake Up Call!"
  • The challenge aims to leverage generative AI to develop open-source hardware accelerators on the Caravel System-on-Chip (SoC) designed explicitly for Keyword Spotting (KWS) applications.
  • This contest emphasizes the integration of generative AI tools like chatGPT, Gemini, Claude, and Copilot with Efabless’ chipIgnite platform, targeting the creation of cutting-edge KWS accelerators.
  • The challenge will enable not only the fabrication of their designs but also provide public recognition and promotional support from Efabless.

Microchip Technology Expands TrustFLEX Family with CEC1736 Real-time Platform Root of Trust Devices

Retrieved on: 
Tuesday, March 26, 2024
SOC, Microchip Technology, NIST, OCP, Configurator, Trust, Ecosystem, Hertz, Integrated circuit, Video game

CHANDLER, Ariz., March 26, 2024 (GLOBE NEWSWIRE) -- As technology and cybersecurity standards continue to evolve, Microchip Technology (Nasdaq: MCHP) is helping make embedded security solutions more accessible with its CEC1736 TrustFLEX devices .

Key Points: 
  • CHANDLER, Ariz., March 26, 2024 (GLOBE NEWSWIRE) -- As technology and cybersecurity standards continue to evolve, Microchip Technology (Nasdaq: MCHP) is helping make embedded security solutions more accessible with its CEC1736 TrustFLEX devices .
  • The CEC1736 Trust Shield family is a microcontroller-based platform root of trust solution enabling cyber resiliency for data centers, telecom, networking, embedded computing and industrial applications.
  • Now, as part of the TrustFLEX platform, the devices are partially configured and provisioned with Microchip-signed Soteria-G3 firmware to reduce the development time needed to integrate platform root of trust.
  • Specifically designed to meet NIST 800-193 platform resiliency guidelines, as well as OCP requirements, CEC1736 TrustFLEX devices can support security features necessary to enable hardware root of trust across various markets.

Diakonos Oncology’s Unique Dendritic Cell Vaccine (DOC1021) Improves Survival Compared to Standard of Care in Phase 1 Trial for Glioblastoma

Retrieved on: 
Tuesday, April 9, 2024
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, SOC, Survival, IDH, Patient, GBM, RNA, Protein, AACR, Pancreatic cancer, Neoplasm, Prognosis, Poster, Vaccine, FDA, Angiosarcoma, Pharmaceutical industry

Twelve of 16 patients with newly diagnosed GBM remain alive with no serious adverse events attributable to DOC1021.

Key Points: 
  • Twelve of 16 patients with newly diagnosed GBM remain alive with no serious adverse events attributable to DOC1021.
  • “These very encouraging results support our confidence in the potential for our dendritic cell vaccines to significantly improve the lives of patients with the most deadly cancers,” said Mike Wicks, Diakonos CEO.
  • Despite their challenging prognosis, these patients saw a statistically significant improvement in expected overall survival of 7.7 months for similar patients.
  • Diakonos’ dendritic cell vaccines are made with a patient’s own immune cells combined with RNA and proteins prepared from a sample of their tumor.

Binary Defense Launches “ARC Labs,” a New Threat Research Unit Focused on Proactive Cyber Threat Intelligence

Retrieved on: 
Tuesday, April 9, 2024
Networks, Internet, Security, Other Technology, Technology, Cleveland Browns, Research, SOC, Organization, Natural language processing, XDR, Entrepreneurship, Data analysis, Intelligence, RSAC, Risk, X-Force, Knowledge, NLP, Artificial intelligence, Blog, IBM, MIT Lincoln Laboratory, Heart, ARC, Machine learning, PGA, Defense, Incident, Risk management

Binary Defense , the trusted Managed Detection and Response (“MDR”) and enterprise defense provider, today announced the launch of ARC Labs , a new threat research group utilizing Binary Defense’s unique attacker’s mindset in threat intelligence, threat hunting and detection engineering to proactively identify the top emerging cyber threats.

Key Points: 
  • Binary Defense , the trusted Managed Detection and Response (“MDR”) and enterprise defense provider, today announced the launch of ARC Labs , a new threat research group utilizing Binary Defense’s unique attacker’s mindset in threat intelligence, threat hunting and detection engineering to proactively identify the top emerging cyber threats.
  • ARC Labs serves as the nexus of advanced research, data analysis and content creation, aimed at empowering security professionals, enhancing Binary Defense capabilities and advancing industry collaboration.
  • Dwyer will also oversee Binary Defense’s broader research efforts, intelligence sharing and public disclosures, while coordinating with the company’s Threat Hunting, Threat Intelligence and Counterintelligence teams.
  • Binary Defense is also the Trusted Cybersecurity Partner of the Cleveland Browns and partners with PGA TOUR players.

Stellar Cyber Named as a Representative Vendor in the 2024 Gartner® Market Guide for Network Detection and Response

Retrieved on: 
Monday, April 8, 2024
Software, Networks, Internet, Hardware, Artificial Intelligence, Data Management, Technology, Security, Stellar, SOC, Risk management, Platform, XDR, SVP, Research, AI, Marketing, Publication, Infrastructure as a service, NDR

Stellar Cyber, the innovator of Open XDR technology, has been included as a Representative Vendor in the Gartner report, Market Guide for Network Detection and Response.

Key Points: 
  • Stellar Cyber, the innovator of Open XDR technology, has been included as a Representative Vendor in the Gartner report, Market Guide for Network Detection and Response.
  • As the report points out, "The network detection and response market continues to grow and expand to hybrid network scenarios with IaaS deployments.
  • Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact.
  • Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

SiFive Unveils the HiFive Premier P550, the First Commercially Available Out-of-Order RISC-V Development Board

Retrieved on: 
Tuesday, April 9, 2024
Technology, Hardware, Artificial Intelligence, Semiconductor, Arrow Electronics, Freedom, SOC, DSP, Documentation, GPU, Growth, Hi-Five, Memory, MIPI, Canonical, PCI Express, DDR5, MultiMediaCard, AI, Linux, Silicon, Electronics, MIPI DSI, IP, SiFive, NPU, SOM, Video game

Today at Embedded World, SiFive, Inc., the pioneer and leader of RISC-V computing, unveiled its new state-of-the-art RISC-V development board, the HiFive™ Premier P550.

Key Points: 
  • Today at Embedded World, SiFive, Inc., the pioneer and leader of RISC-V computing, unveiled its new state-of-the-art RISC-V development board, the HiFive™ Premier P550.
  • With a quad-core SiFive Performance™ P550 processor, the HiFive Premier P550 is the highest performance RISC-V development board in the industry, and the latest in the popular HiFive family.
  • “Thanks to our collaboration with SiFive, developers using the HiFive Premier P550 board will be able to innovate at speed with Ubuntu.
  • To help streamline the development process, SiFive provides comprehensive documentation, software development kits, toolchains, utilities, and software ecosystem solutions for each SiFive RISC-V development board.

SpaceBilt and Phison Skyrocket to International Space Station in 2025

Retrieved on: 
Monday, April 8, 2024
Aerospace, Hardware, Manufacturing, Data Management, Technology, Radiation, SOC, SSD, Risk, X1, CASIS, International Space Station, Moon, Space Symposium, Linux, Defense Innovation Unit, ISS, Solid-state drive, NVIDIA, ISS National Lab, Integrated circuit, Engineering, Liss, Video game

SpaceBilt Inc., today announced it has partnered with Phison to fly the Large in Space Server (LiSS), the world’s first 100 terabyte plus data storage and edge compute center to the International Space Station (ISS) in 2025.

Key Points: 
  • SpaceBilt Inc., today announced it has partnered with Phison to fly the Large in Space Server (LiSS), the world’s first 100 terabyte plus data storage and edge compute center to the International Space Station (ISS) in 2025.
  • SpaceBilt and partner Novium will provide demonstrations of a mockup space station at the Space Symposium from April 8 - 11, 2024 in Colorado Springs, Colo.
  • Phison is supplying the technical expertise to enable SpaceBilt to access engineering data associated with the performance of the X1 SSD drives in the radiation and vacuum environment of space.
  • Phison’s upcoming SpaceBilt flight to the International Space Station marks a return to space for the company.

Imagination’s New Catapult CPU Is Driving RISC-V Device Adoption

Retrieved on: 
Monday, April 8, 2024
Consumer Electronics, Technology, Professional Services, Venture Capital, Security, Apps, Applications, Software, Artificial Intelligence, Networks, Hardware, Electronic Design Automation, Socs, SOC, GPU, QEMU, Growth, PowerVR, Environment, Partnership, Risk, Knowledge, Artificial intelligence, IDE, AI, Linux, Digital signage, Silicon, Imagination Technologies, Software development kit, Catapult, Visual Studio, Architecture, Computing, Lauterbach, Engineering, IP, Marketplace, CPU, Intellectual property, SDK, PPA, Central processing unit, Android, Video game

“One fifth of all consumer devices will have a RISC-V based CPU by the end of this decade.

Key Points: 
  • “One fifth of all consumer devices will have a RISC-V based CPU by the end of this decade.
  • Imagination is set to be a force in RISC-V with a strategy that prioritises quality and ease of adoption.
  • Now, any Visual Studio user can visit the Marketplace and install the Catapult extension into their regular development environment.
  • Its GPU, CPU, and AI technologies enable outstanding power, performance, and area (PPA), fast time-to-market, and lower total cost of ownership.